1 reports of this reaction
12.5% of all PAIN RELIEF PATCH reports
#6 most reported adverse reaction
RASH PAPULAR is the #6 most commonly reported adverse reaction for PAIN RELIEF PATCH, manufactured by Bionpharma Inc.. There are 1 FDA adverse event reports linking PAIN RELIEF PATCH to RASH PAPULAR. This represents approximately 12.5% of all 8 adverse event reports for this drug.
Patients taking PAIN RELIEF PATCH who experience rash papular should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH PAPULAR is a frequently reported adverse event for PAIN RELIEF PATCH, accounting for a significant proportion of all reports.
In addition to rash papular, the following adverse reactions have been reported for PAIN RELIEF PATCH:
The following drugs have also been linked to rash papular in FDA adverse event reports:
RASH PAPULAR has been reported as an adverse event in 1 FDA reports for PAIN RELIEF PATCH. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH PAPULAR accounts for approximately 12.5% of all adverse event reports for PAIN RELIEF PATCH, making it a notable side effect.
If you experience rash papular while taking PAIN RELIEF PATCH, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.